Fennec Pharmaceuticals Logo Image

Fennec Pharmaceuticals

Most Recent Annual Report

2017 Annual Report and Form 10K

Fennec Pharmaceuticals

Archived Annual Reports

  • Fennec Pharmaceuticals
  • Fennec Pharmaceuticals

About Fennec Pharmaceuticals

1-10 Employees
Based in Research Triangle Park, North Carolina

Fennec Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol